BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9549756)

  • 1. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.
    Yabe-Nishimura C
    Pharmacol Rev; 1998 Mar; 50(1):21-33. PubMed ID: 9549756
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldose reductase and its inhibition in the control of diabetic complications.
    Narayanan S
    Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase inhibitors and diabetic kidney disease.
    Oates PJ
    Curr Opin Investig Drugs; 2010 Apr; 11(4):402-17. PubMed ID: 20336588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of aldose reductase inhibitors in diabetic complications: recent trends.
    Kaul CL; Ramarao P
    Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aldose reductase inhibitors].
    Yoneta T; Tagashira E
    Nihon Rinsho; 1991 Sep; 49(9):2017-23. PubMed ID: 1960870
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
    El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
    Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic cataracts and flavonoids.
    Varma SD; Mizuno A; Kinoshita JH
    Science; 1977 Jan; 195(4274):205-6. PubMed ID: 401544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of aldose reductase by nonenzymatic glycosylation.
    Srivastava SK; Ansari NH; Bhatnagar A; Hair G; Liu S; Das B
    Prog Clin Biol Res; 1989; 304():171-84. PubMed ID: 2506561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the polyol pathway in diabetes mellitus.
    Collier A; Small M
    Br J Hosp Med; 1991 Jan; 45(1):38-40. PubMed ID: 1901236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of chronic complications of diabetes mellitus with aldose reductase inhibitors].
    Cattalini M; Lerario AC
    Rev Assoc Med Bras (1992); 1996; 42(2):109-14. PubMed ID: 9110460
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldose reductase inhibitors.
    Kirchain WR; Rendell MS
    Pharmacotherapy; 1990; 10(5):326-36. PubMed ID: 2122421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discoveries in research on diabetic keratopathy.
    Cisarik-Fredenburg P
    Optometry; 2001 Nov; 72(11):691-704. PubMed ID: 12363257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All in the family: aldose reductase and closely related aldo-keto reductases.
    Petrash JM
    Cell Mol Life Sci; 2004 Apr; 61(7-8):737-49. PubMed ID: 15094999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monkey 3-deoxyglucosone reductase: tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase, and aldose reductase.
    Sato K; Inazu A; Yamaguchi S; Nakayama T; Deyashiki Y; Sawada H; Hara A
    Arch Biochem Biophys; 1993 Dec; 307(2):286-94. PubMed ID: 8274014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate specificity of reduced and oxidized forms of human aldose reductase.
    Vander Jagt DL; Hunsaker LA
    Adv Exp Med Biol; 1993; 328():279-88. PubMed ID: 8493905
    [No Abstract]   [Full Text] [Related]  

  • 16. Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications.
    Giannoukakis N
    Expert Opin Investig Drugs; 2008 Apr; 17(4):575-81. PubMed ID: 18363521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
    Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges.
    ElGamal H; Munusamy S
    Protein Pept Lett; 2017; 24(1):71-77. PubMed ID: 27894247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase inhibitors and nanodelivery of diabetic therapeutics.
    Prior AM; Thapa M; Hua DH
    Mini Rev Med Chem; 2012 Apr; 12(4):326-36. PubMed ID: 22303947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress in aldose reductase].
    Gu J; Yan J; Wu W; Huang Q; Ouyang D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 35(4):395-400. PubMed ID: 20448367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.